Skip to main content

Published locations for FDA expands approval of fulvestrant for HR+/HER2– advanced breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands approval of fulvestrant for HR+/HER2– advanced breast cancer

User login

  • Reset your password
  • /content/fda-expands-approval-fulvestrant-hr/her2-advanced-breast-cancer
  • /obgynnews/article/145748/breast-cancer/fda-expands-approval-fulvestrant-hr/her2-advanced-breast
  • /oncologypractice/article/145748/breast-cancer/fda-expands-approval-fulvestrant-hr/her2-advanced
  • /obgyn/article/145748/breast-cancer/fda-expands-approval-fulvestrant-hr/her2-advanced-breast-cancer
  • /hematology-oncology/article/145748/breast-cancer/fda-expands-approval-fulvestrant-hr/her2-advanced
  • /breast-cancer-icymi/article/145748/breast-cancer/fda-expands-approval-fulvestrant-hr/her2-advanced